LTL Bankruptcy Judge Receiving Angry Responses For Protecting Johnson & Johnson

Many think that the LTL bankruptcy is unfair and will result in plaintiffs waiting longer to get less

Tuesday, December 6, 2022 - Talcum powder lawsuits against Johnson & Johnson have been put on hold by the company's restructuring of its talcum powder business into a separate company LTL Management. The legal maneuver is intended to shelter their $400 billion in liquid assets from the claims of plaintiffs that have or have died from ovarian cancer. Experts including bankruptcy judge Kaplan overseeing the restructuring think that bankruptcy offers the masses of plaintiffs the best chance of receiving money rapidly. AboutLawsuits.com recently wrote, "The federal judge overseeing bankruptcy proceedings involving a Johnson & Johnson subsidiary has assigned an independent expert to help assess the value of talcum powder lawsuits being filed by thousands of woman diagnosed with talcum powder cancer and other injuries, to help break a logjam which has stalled settlement talks." One estimate is that it could cost upwards of $60 billion to settle the existing lawsuits. Judge Kaplan's decision to allow bankruptcy protection to LTL management is being appealed and a decision could be forthcoming. Judge Kaplan has told reporters that he expected blow-back from plaintiff attorneys and legal scholars over his decision to allow the bankruptcy. "he has received threats related to the bankruptcy of a Johnson & Johnson subsidiary he is overseeing, with some messages suggesting that the case is an effort to "cover-up" harms allegedly caused by J&J's talc products. Chief U.S. Bankruptcy Judge Michael Kaplan in Trenton, New Jersey said at a hearing that he and his staff have been getting angry and menacing messages through phone calls, voicemails, emails, and social media posts since his February decision not to dismiss the bankruptcy case of LTL Management LLC, "Reuters reports.

Some of the biggest news of 2022 turns out to be that Johnson & Johnson will discontinue selling its iconic baby care product Johnson's Baby Powder worldwide in 2023. The move follows the company's decision last year to stop selling talcum powder in North America. Existing inventories of the product on store shelves and warehouses will continue to be made available. By and large, Johnson & Johnson has replaced its talc-based baby care product with baby powder made from corn starch. Corn starch has none of the stigmas that were attached to talc after global health governing bodies such as the IARC decided that talc was probably carcinogenic. In addition, The US Food and Drug Administration (FDA) tested bottles of Johnson's Baby Powder procured from retailers Walmart, CVS, and Rite Aid and found them to contain asbestos, a known deadly carcinogen. Asbestos is believed to be the cause of mesothelioma, a type of lung cancer that destroys the delicate lining of the lungs. Several talcum product manufacturers continue to sell talcum powder with a mesothelioma and ovarian cancer warning label. Johnson & Johnson characterized their decision to discontinue selling talcum powder as part of an overall restructuring strategy and that the decision had nothing to do with the 40,000 or so ovarian cancer and mesothelioma lawsuits currently pending against them. Johnson's Baby Powder customers largely feel deceived after purchasing baby powder with corn starch after expecting talc. ">

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.